Banzel Oral Suspension

— THERAPEUTIC CATEGORIES —
  • Seizure disorders

Banzel Oral Suspension Generic Name & Formulations

General Description

Rufinamide 40mg/mL; orange-flavor; lactose-, gluten-, and dye-free.

Pharmacological Class

Antiepileptic.

See Also

How Supplied

Tabs—120; Susp—460mL (w. adapter & dosing syringe)

Manufacturer

Banzel Oral Suspension Indications

Indications

Adjunctive treatment of seizures in Lennox-Gastaut syndrome.

Banzel Oral Suspension Dosage and Administration

Adult

Take with food in 2 equally divided doses. ≥17yrs: initially 400–800mg per day; increase by 400–800mg/day every other day up to max 3200mg/day. Avoid abrupt cessation (reduce dose by 25% every 2 days).

Children

<1yrs: not established. Take with food in 2 equally divided doses. 1–<17yrs: initially 10mg/kg per day; increase every other day by 10mg/kg up to max 45mg/kg per day or 3200mg/day (whichever is less). Avoid abrupt cessation (reduce dose by 25% every 2 days).

Banzel Oral Suspension Contraindications

Contraindications

Familial short QT syndrome.

Banzel Oral Suspension Boxed Warnings

Not Applicable

Banzel Oral Suspension Warnings/Precautions

Warnings/Precautions

Increased risk of suicidal thoughts or behavior; monitor for new or worsening of depression, suicidal thoughts, or unusual changes. Severe hepatic impairment: not recommended. Mild to moderate hepatic impairment. Dialysis (may adjust dose). Monitor for multi-organ hypersensitivity reactions; discontinue if suspected. Pregnancy. Nursing mothers.

Banzel Oral Suspension Pharmacokinetics

See Literature

Banzel Oral Suspension Interactions

Interactions

Caution with drugs that shorten QT interval. CNS depression with alcohol, other CNS depressants. Antagonizes carbamazepine, lamotrigine, triazolam. May potentiate phenobarbital, phenytoin. Potentiated by valproate (reduce doses). Antagonized by carbamazepine, phenobarbital, primidone, phenytoin. May affect substrates of CYP3A4, CYP2E1 (monitor). Antagonizes hormonal contraceptives (use additional non-hormonal forms). May be affected by inducers or inhibitors of carboxylesterases.

Banzel Oral Suspension Adverse Reactions

Adverse Reactions

Headache, dizziness, fatigue, somnolence, nausea, incoordination, gait disturbances, ataxia, visual disturbances, leukopenia, fever/rash.

Banzel Oral Suspension Clinical Trials

See Literature

Banzel Oral Suspension Note

Not Applicable

Banzel Oral Suspension Patient Counseling

See Literature

Images